Skip to Main Content

Author Details

Puey Ling Chia
Lee Kong Chian School of Medicine, Nanyang Technological University
2009
22
8
PMIDPaper TitleJournal TitlePublished Year
37161643Editorial Comment to Impact of the coronavirus disease-2019 pandemic on the number of patients undergoing radical nephroureterectomy and postoperative adjuvant systematic therapy for upper tract urothelial carcinomas in Japan: A multicenter retrospective study.Int J Urol2023
37551698Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer.Expert Rev Anticancer Ther2023
35144319Editorial Comment to Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.Int J Urol2022
35958327Resectable non-small cell lung cancer: an evolving landscape.Transl Lung Cancer Res2022
33453471Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival.Lung Cancer2021
34034887Lung Cancer in Singapore.J Thorac Oncol2021
33023139Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma.Pharmaceuticals (Basel)2020
33035778Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort.Lung Cancer2020
32847977Targeting Multiple EGFR-expressing Tumors with a Highly Potent Tumor-selective Antibody-Drug Conjugate.Mol Cancer Ther2020
30701671Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study.Asia Pac J Clin Oncol2019
30916586Epidermal growth factor receptor (EGFR)-targeted therapies in mesothelioma.Expert Opin Drug Deliv2019
29351918Personalized Chemosensitivity Assays for Mesothelioma: Are They Worth the Effort?Clin Cancer Res2018
29284360The utility of routine pre-chemotherapy screening with cardiac gated blood pool scan for patients at low risk of anthracycline toxicity.J Oncol Pharm Pract2018
28891180De novo activating epidermal growth factor mutations (EGFR) in small-cell lung cancer.Intern Med J2017
28795492Treatment of ALK-rearranged non-small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context.Asia Pac J Clin Oncol2017
27245079Current and Evolving Methods to Visualize Biological Data in Cancer Research.J Natl Cancer Inst2016
27696931Targeting the vasculature: anti-angiogenic agents for malignant mesothelioma.Expert Rev Anticancer Ther2016
27393503Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatment.Lung Cancer2016
27163740Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC).J Immunother2016
26709481Vortex Keratopathy Presumed Secondary to AZD9291.J Thorac Oncol2015
25429239Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitors.Clin Epidemiol2014
19433596A case of persistent vomiting.Gut2009
  • 1 - 22 of 22

Recommended Authors

Jyoti Malhotra
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School
Career Start Year 2012
Number of shared co-authors 0
Gareth Rivalland
Auckland City Hospital
Career Start Year 2010
Number of shared co-authors 10
Caroline E McCoach
UCSF Helen Diller Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 1
Alexandra Drakaki
David Geffen School of Medicine at university of california los angeles
Career Start Year 2009
Number of shared co-authors 1
Gideon M Blumenthal
Oncology Center of Excellence
Career Start Year 2008
Number of shared co-authors 1
Ashiq Masood
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Career Start Year 2008
Number of shared co-authors 1
Bishoy M Faltas
Sandra and Edward Meyer Cancer Center
Career Start Year 2007
Number of shared co-authors 0
Iacopo Petrini
University of Pisa
Career Start Year 2006
Number of shared co-authors 0
Edward B Garon
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2005
Number of shared co-authors 1
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Matthew A Gubens
University of California san francisco
Career Start Year 2003
Number of shared co-authors 0
Lecia V Sequist
Massachusetts General Hospital Cancer Center, Harvard Medical School
Career Start Year 2003
Number of shared co-authors 2
Philippe L Bedard
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 1
Daniel Morgensztern
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Fiona Blackhall
The University of Manchester
Career Start Year 2000
Number of shared co-authors 5
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 2
Primo N Lara
University of California Davis Comprehensive Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Nam Bui
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Cheryl Ho
University of British Columbia
Career Start Year 1995
Number of shared co-authors 3
Gregory J Riely
Memorial Sloan Kettering Cancer Center
Career Start Year 1994
Number of shared co-authors 2
Stefan Sleijfer
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
Vincent A Miller
Injury Prevention Research Center, University of North Carolina
Career Start Year 1994
Number of shared co-authors 1
Jonathan W Goldman
David Geffen School of Medicine at university of california los angeles
Career Start Year 1991
Number of shared co-authors 2
Dean A Fennell
University of Leicester
Career Start Year 1990
Number of shared co-authors 3
Suresh Nair
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 1
Pasi A J??nne
Dana-Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 4
Roy S Herbst
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 2
Giuseppe Giaccone
Meyer Cancer Center
Career Start Year 1981
Number of shared co-authors 2
Ramaswamy Govindan
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 3
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Thomas John
Peter MacCallum Cancer Centre
Co-authored papers 14
Prudence A Russell
St Vincent's Hospital
Co-authored papers 4
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Co-authored papers 4
Bibhusal Thapa
Northern Hospital
Co-authored papers 2
Carmel Murone
Olivia Newton-John Cancer Research Institute
Co-authored papers 2
Marzena Walkiewicz
Olivia Newton-John Cancer Research Institute
Co-authored papers 2
Paul Wheatley-Price
The Ottawa Hospital Research Institute
Co-authored papers 1
Khashayar Asadi
Austin Hospital
Co-authored papers 1
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 1
Benjamin Solomon
Peter MacCallum Cancer Centre
Co-authored papers 1
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Co-authored papers 1
Adrienne Morey
The Canberra Hospital
Co-authored papers 1
Release 1.2